Correlation Analysis of POD and pNCD in Elderly Spinal Surgery Patients
Launched by XUANWU HOSPITAL, BEIJING · Jun 13, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how certain blood markers relate to two conditions that can affect elderly patients after spinal surgery: postoperative delirium (POD), which is a temporary confusion or disorientation, and postoperative neurocognitive disorder (pNCD), which is a more lasting decline in thinking and memory. The researchers want to see if there are differences in these blood markers between patients who experience POD but do not develop pNCD and those who do. Understanding this relationship could help doctors better predict and manage these conditions in older adults.
To participate in this study, you need to be at least 65 years old and have had spinal surgery. Researchers will ask patients to give their consent and complete some tests to assess their thinking abilities. Some individuals, like those with severe psychiatric or neurological conditions, may not be eligible to join. If you are chosen to participate, you can expect to provide blood samples and answer questions about your health during the study. This research could provide valuable insights into improving care for elderly patients undergoing spinal surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients ≥65 years of age who have undergone spinal surgery anesthesia; Sign informed consent
- Exclusion Criteria:
- • Inability to complete cognitive function assessment; Illiteracy, hearing impairment or visual impairment; He has a history of epilepsy, depression, schizophrenia, Alzheimer's disease and other psychiatric and neurological diseases
About Xuanwu Hospital, Beijing
Xuanwu Hospital, located in Beijing, is a leading clinical research institution renowned for its commitment to advancing medical knowledge and improving patient care. Affiliated with Capital Medical University, the hospital specializes in neurology and rehabilitation, providing a robust framework for innovative clinical trials. With a multidisciplinary team of experienced researchers and healthcare professionals, Xuanwu Hospital focuses on conducting high-quality, ethically sound studies that aim to explore new treatment modalities and enhance therapeutic outcomes. Through its dedication to research excellence and patient-centered approaches, Xuanwu Hospital plays a pivotal role in the advancement of healthcare solutions both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, , China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported